Brand family
Xigduo XR
Dapagliflozin propanediol and Metformin · AstraZeneca Pharmaceuticals
United States
- Presentations
- 5
- Markets
- 1
Xigduo XR is a brand of Dapagliflozin propanediol and Metformin marketed by AstraZeneca Pharmaceuticals, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Dapagliflozin propanediol and Metformin
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 10 mg/1000 mg extended-release tablet, 10 mg/500 mg extended-release tablet, 2.5 mg/1000 mg extended-release tablet, 5 mg/1000 mg extended-release tablet, 5 mg/500 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Xigduo XR 10 mg/1000 mg extended-release tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Xigduo XR 10 mg/500 mg extended-release tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Xigduo XR 2.5 mg/1000 mg extended-release tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Xigduo XR 5 mg/1000 mg extended-release tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Xigduo XR 5 mg/500 mg extended-release tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Xigduo XR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.